AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update

AngioDynamics, Inc. (NASDAQ:ANGO) was the recipient of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 1,220,000 shares, a growth of 24.7% from the August 15th total of 978,700 shares. Currently, 3.2% of the company’s stock are sold short. Based on an average trading volume of 474,000 shares, the short-interest ratio is currently 2.6 days.

Institutional Trading of AngioDynamics

A number of hedge funds have recently made changes to their positions in ANGO. Nuveen Asset Management LLC lifted its position in AngioDynamics by 18.3% in the 2nd quarter. Nuveen Asset Management LLC now owns 507,253 shares of the medical instruments supplier’s stock valued at $5,291,000 after acquiring an additional 78,438 shares in the last quarter. Alliancebernstein L.P. lifted its position in AngioDynamics by 11.5% in the 2nd quarter. Alliancebernstein L.P. now owns 42,580 shares of the medical instruments supplier’s stock valued at $444,000 after acquiring an additional 4,380 shares in the last quarter. Wells Fargo & Company MN lifted its position in AngioDynamics by 67.4% in the 2nd quarter. Wells Fargo & Company MN now owns 16,585 shares of the medical instruments supplier’s stock valued at $173,000 after acquiring an additional 6,676 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in AngioDynamics by 271.7% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 33,462 shares of the medical instruments supplier’s stock valued at $349,000 after acquiring an additional 24,459 shares in the last quarter. Finally, Walleye Capital LLC bought a new position in AngioDynamics in the 2nd quarter valued at approximately $319,000. 90.52% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ANGO has been the topic of a number of research analyst reports. Canaccord Genuity Group upped their target price on AngioDynamics from $18.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, July 13th. StockNews.com initiated coverage on AngioDynamics in a report on Thursday, August 17th. They set a “hold” rating on the stock.

AngioDynamics Stock Performance

Shares of ANGO opened at $7.30 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.95 and a debt-to-equity ratio of 0.13. The business’s 50 day moving average price is $8.42 and its 200-day moving average price is $9.59. AngioDynamics has a 52 week low of $6.72 and a 52 week high of $22.00. The stock has a market cap of $289.60 million, a P/E ratio of -5.53 and a beta of 0.61.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings results on Wednesday, July 12th. The medical instruments supplier reported $0.02 EPS for the quarter, hitting analysts’ consensus estimates of $0.02. AngioDynamics had a negative return on equity of 0.61% and a negative net margin of 15.48%. The firm had revenue of $91.10 million for the quarter, compared to analysts’ expectations of $90.73 million. During the same period in the previous year, the firm posted $0.01 EPS. The business’s revenue for the quarter was up 4.7% compared to the same quarter last year. Equities research analysts anticipate that AngioDynamics will post -0.33 earnings per share for the current fiscal year.

AngioDynamics Company Profile

AngioDynamics, Inc provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease.